![References in Drug–drug interactions with tyrosine-kinase inhibitors: a clinical perspective - The Lancet Oncology References in Drug–drug interactions with tyrosine-kinase inhibitors: a clinical perspective - The Lancet Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/5bf0987b-81a8-4c26-bdf3-6afece0bb772/gr1_lrg.jpg)
References in Drug–drug interactions with tyrosine-kinase inhibitors: a clinical perspective - The Lancet Oncology
![Screening of cytochrome P450 3A4 inhibitors via in silico and in vitro approaches - RSC Advances (RSC Publishing) DOI:10.1039/C8RA06311G Screening of cytochrome P450 3A4 inhibitors via in silico and in vitro approaches - RSC Advances (RSC Publishing) DOI:10.1039/C8RA06311G](https://pubs.rsc.org/image/article/2018/RA/c8ra06311g/c8ra06311g-f4_hi-res.gif)
Screening of cytochrome P450 3A4 inhibitors via in silico and in vitro approaches - RSC Advances (RSC Publishing) DOI:10.1039/C8RA06311G
![توییتر \ Arden Barry در توییتر: "The "need to know" CYP3A4 cardiac substrates and strong inducers/inhibitors from our drug interaction workshop at #CCCVan https://t.co/of9p4mJlsj" توییتر \ Arden Barry در توییتر: "The "need to know" CYP3A4 cardiac substrates and strong inducers/inhibitors from our drug interaction workshop at #CCCVan https://t.co/of9p4mJlsj"](https://pbs.twimg.com/media/DMxdXL7U8AAVNRK.jpg)
توییتر \ Arden Barry در توییتر: "The "need to know" CYP3A4 cardiac substrates and strong inducers/inhibitors from our drug interaction workshop at #CCCVan https://t.co/of9p4mJlsj"
![Table 2 from The pharmacological importance of cytochrome CYP3A4 in the palliation of symptoms: review and recommendations for avoiding adverse drug interactions | Semantic Scholar Table 2 from The pharmacological importance of cytochrome CYP3A4 in the palliation of symptoms: review and recommendations for avoiding adverse drug interactions | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/3e764a8aa3ed07fa458b6b76afb0e045320d49ad/3-Table2-1.png)
Table 2 from The pharmacological importance of cytochrome CYP3A4 in the palliation of symptoms: review and recommendations for avoiding adverse drug interactions | Semantic Scholar
![Review article: cytochrome P450 and the metabolism of proton pump inhibitors — emphasis on rabeprazole - Ishizaki - 1999 - Alimentary Pharmacology & Therapeutics - Wiley Online Library Review article: cytochrome P450 and the metabolism of proton pump inhibitors — emphasis on rabeprazole - Ishizaki - 1999 - Alimentary Pharmacology & Therapeutics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/a0309c4e-9e4e-4384-b6ed-6b16b6df5386/apt_022_t1.gif)
Review article: cytochrome P450 and the metabolism of proton pump inhibitors — emphasis on rabeprazole - Ishizaki - 1999 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
![Clinical Pharmacology Considerations in Pain Management in Patients with Advanced Kidney Failure | American Society of Nephrology Clinical Pharmacology Considerations in Pain Management in Patients with Advanced Kidney Failure | American Society of Nephrology](https://cjasn.asnjournals.org/content/clinjasn/early/2019/03/02/CJN.05180418/F2.large.jpg)
Clinical Pharmacology Considerations in Pain Management in Patients with Advanced Kidney Failure | American Society of Nephrology
![Computation | Free Full-Text | Exploring the Chemical Space of Cytochrome P450 Inhibitors Using Integrated Physicochemical Parameters, Drug Efficiency Metrics and Decision Tree Models | HTML Computation | Free Full-Text | Exploring the Chemical Space of Cytochrome P450 Inhibitors Using Integrated Physicochemical Parameters, Drug Efficiency Metrics and Decision Tree Models | HTML](https://www.mdpi.com/computation/computation-07-00026/article_deploy/html/images/computation-07-00026-g001.png)